Pfizer Inc
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.67+0.15 (+0.49%)
Close on Nov 2, 2026Market cap $174.81BP/E 40.4Yield 5.61%
Pfizer DB Geography by Quarter
DB Geography — International Emerging Markets Revenues ($M) ($M)
Pfizer DB Geography: $2,434M in Q2 2026, up 2.9% from a year earlier.
Latest, Q2 2026
2,434
Period ended Jun 28, 2026
Change on a year earlier
+2.9%
2,366 in Q2 2025
History
62 quarters
Since Q1 2011
Sources
47
Documents cited below
Where the Q2 2026 figure comes from
Source: Form 10-Q (filed 2026-08-04) ↗
Reported in Database (SEC Form 10-K / 10-Q XBRL via lib/db.py).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | DB Geography — International Emerging Markets Revenues ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 28, 2026 | 2,434 | +2.9% | Form 10-Q (filed 2026-08-04) ↗ |
| Q1 2026 | Mar 29, 2026 | 2,293 | +6.0% | Form 10-Q (filed 2026-05-05) ↗ |
| Q4 2025 | Dec 31, 2025 | 2,517 | +11.4% | Form 10-K (filed 2026-02-26) ↗ |
| Q3 2025 | Sep 28, 2025 | 2,267 | +1.8% | Form 10-Q (filed 2025-11-04) ↗ |
| Q2 2025 | Jun 29, 2025 | 2,366 | +6.2% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2025 | Mar 30, 2025 | 2,163 | -0.2% | Form 10-Q (filed 2025-05-05) ↗ |
| Q4 2024 | Dec 31, 2024 | 2,259 | +22.6% | Form 10-K (filed 2025-02-27) ↗ |
| Q3 2024 | Sep 29, 2024 | 2,226 | +6.4% | Form 10-Q (filed 2024-11-04) ↗ |
| Q2 2024 | Jun 30, 2024 | 2,227 | -8.1% | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | 2,167 | -47.7% | Form 10-Q (filed 2024-05-08) ↗ |
| Q4 2023 | Dec 31, 2023 | 1,842 | -46.2% | Form 10-K (filed 2025-02-27) ↗ |
| Q3 2023 | Oct 1, 2023 | 2,092 | -36.6% | Form 10-Q (filed 2024-11-04) ↗ |
| Q2 2023 | Jul 2, 2023 | 2,423 | -59.7% | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2023 | Apr 2, 2023 | 4,140 | -43.8% | Form 10-Q (filed 2024-05-08) ↗ |
| Q4 2022 | Dec 31, 2022 | 3,424 | -55.9% | Form 10-K (filed 2023-02-23) ↗ |
| Q3 2022 | Oct 2, 2022 | 3,300 | -47.6% | Form 10-Q (filed 2022-11-09) ↗ |
| Q2 2022 | Jul 3, 2022 | 6,006 | +57.6% | Form 10-Q (filed 2022-08-10) ↗ |
| Q1 2022 | Apr 3, 2022 | 7,367 | +160.9% | Form 10-Q (filed 2022-05-11) ↗ |
| Q4 2021 | Dec 31, 2021 | 7,771 | +225.7% | Form 10-K (filed 2022-02-24) ↗ |
| Q3 2021 | Oct 3, 2021 | 6,296 | +227.4% | Form 10-Q (filed 2021-11-12) ↗ |
| Q2 2021 | Jul 4, 2021 | 3,810 | +100.8% | Form 10-Q (filed 2021-08-12) ↗ |
| Q1 2021 | Apr 4, 2021 | 2,824 | +30.4% | Form 10-Q (filed 2021-05-13) ↗ |
| Q4 2020 | Dec 31, 2020 | 2,386 | -26.4% | Form 10-Q (filed 2021-11-12) ↗ |
| Q3 2020 | Sep 27, 2020 | 1,923 | -38.2% | Form 10-Q (filed 2021-11-12) ↗ |
| Q2 2020 | Jun 28, 2020 | 1,897 | -38.0% | Form 10-Q (filed 2021-08-12) ↗ |
| Q1 2020 | Mar 29, 2020 | 2,166 | -34.8% | Form 10-Q (filed 2021-05-13) ↗ |
| Q4 2019 | Dec 31, 2019 | 3,240 | -1.6% | Form 10-K (filed 2020-02-27) ↗ |
| Q3 2019 | Sep 29, 2019 | 3,110 | +1.4% | Form 10-Q (filed 2019-11-07) ↗ |
| Q2 2019 | Jun 30, 2019 | 3,062 | -4.7% | Form 10-Q (filed 2019-08-08) ↗ |
| Q1 2019 | Mar 31, 2019 | 3,322 | +7.9% | Form 10-Q (filed 2019-05-09) ↗ |
| Q4 2018 | Dec 31, 2018 | 3,293 | +3.7% | Form 10-K (filed 2019-02-28) ↗ |
| Q3 2018 | Sep 30, 2018 | 3,066 | +8.0% | Form 10-Q (filed 2018-11-08) ↗ |
| Q2 2018 | Jul 1, 2018 | 3,214 | +14.2% | Form 10-Q (filed 2018-08-09) ↗ |
| Q1 2018 | Apr 1, 2018 | 3,078 | +19.9% | Form 10-Q (filed 2018-05-10) ↗ |
| Q4 2017 | Dec 31, 2017 | 3,177 | +17.4% | Form 10-K (filed 2018-02-22) ↗ |
| Q3 2017 | Oct 1, 2017 | 2,839 | +9.8% | SEC Filing ↗ |
| Q2 2017 | Jul 2, 2017 | 2,815 | +6.4% | SEC Filing ↗ |
| Q1 2017 | Apr 2, 2017 | 2,567 | +3.4% | SEC Filing ↗ |
| Q4 2016 | Dec 31, 2016 | 2,706 | -6.5% | Form 10-K (filed 2017-02-23) ↗ |
| Q3 2016 | Oct 2, 2016 | 2,586 | -4.0% | SEC Filing ↗ |
| Q2 2016 | Jul 3, 2016 | 2,646 | -9.4% | SEC Filing ↗ |
| Q1 2016 | Apr 3, 2016 | 2,482 | -5.5% | SEC Filing ↗ |
| Q4 2015 | Dec 31, 2015 | 2,893 | -6.1% | Form 10-K (filed 2016-02-29) ↗ |
| Q3 2015 | Sep 27, 2015 | 2,694 | -6.0% | SEC Filing ↗ |
| Q2 2015 | Jun 28, 2015 | 2,921 | -2.6% | SEC Filing ↗ |
| Q1 2015 | Mar 29, 2015 | 2,626 | +2.8% | SEC Filing ↗ |
| Q4 2014 | Dec 31, 2014 | 3,080 | +1.7% | Form 10-K (filed 2015-02-27) ↗ |
| Q3 2014 | Sep 28, 2014 | 2,866 | +6.9% | Form 10-Q (filed 2014-11-06) ↗ |
| Q2 2014 | Jun 29, 2014 | 2,998 | +4.8% | Form 10-Q (filed 2014-08-07) ↗ |
| Q1 2014 | Mar 30, 2014 | 2,555 | -3.9% | Form 10-Q (filed 2014-05-08) ↗ |
| Q4 2013 | Dec 31, 2013 | 3,030 | +4.3% | Form 10-K (filed 2014-02-28) ↗ |
| Q3 2013 | Sep 29, 2013 | 2,680 | +3.5% | Form 10-Q (filed 2013-11-08) ↗ |
| Q2 2013 | Jun 30, 2013 | 2,862 | +0.6% | Form 10-Q (filed 2013-08-09) ↗ |
| Q1 2013 | Mar 31, 2013 | 2,660 | -4.5% | Form 10-Q (filed 2014-05-08) ↗ |
| Q4 2012 | Dec 31, 2012 | 2,904 | +75.8% | Form 10-K (filed 2014-02-28) ↗ |
| Q3 2012 | Sep 30, 2012 | 2,589 | -10.6% | Form 10-Q (filed 2013-11-08) ↗ |
| Q2 2012 | Jul 1, 2012 | 2,844 | -2.9% | Form 10-Q (filed 2013-08-09) ↗ |
| Q1 2012 | Apr 1, 2012 | 2,784 | -8.7% | Form 10-Q (filed 2013-05-10) ↗ |
| Q4 2011 | Dec 31, 2011 | 1,652 | – | Form 10-K (filed 2014-02-28) ↗ |
| Q3 2011 | Oct 2, 2011 | 2,896 | – | Form 10-Q (filed 2012-11-09) ↗ |
| Q2 2011 | Jul 3, 2011 | 2,930 | – | Form 10-Q (filed 2012-08-09) ↗ |
| Q1 2011 | Apr 3, 2011 | 3,048 | – | Form 10-Q (filed 2012-05-10) ↗ |
Cite this data
StockData. (2026). Pfizer DB Geography ($M), quarterly Q1 2011–Q2 2026 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/db-geo-rev-em
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.